Accessibility
Executive Committee
- Lício Tavares Ângelo Cintra Chief Executive Officer
- André Covre Chief Financial Officer
- Rogerio Reis de Castro Hospital Operations and Oncology Officer
- Maria José Martinez Fernandez Campos People & Culture Officer
- Leonardo Modesti Vedolin Medical Officer
- Rafael Lucchesi Outpatient & Diagnostics Officer
- Nelcina Conceição de Oliveira Legal, Compliance, ESG, Public Relations and Internal Audit Director
- Helisson Brígido Andrade Lemos Product, Marketing, Analytics and Customer Experience Officer (PMAX)
- Linaldo Vilar Junior Production Officer
On June 27, 2023, Lício Tavares Ângelo Cintra was elected by the Board of Directors to hold the position of Chief Operations Officer until January 31, 2024, as part of the succession plan of the current CEO of the Company.
Before joining DASA, he was a member of the Board of Directors and Vice President – M&A and Commercial at Hapvida, besides working for 14 years at Grupo São Franciso, 10 years as head of the Group.
Lício holds a degree in Electrical Engineering from Universidade Presbiteriana Mackenzie, has completed a specialization program in Business Administration from FGV and holds an MBA in Controllership and Finance from USP (FUNDACE) and an International Executive MBA from FIA.
Mr. Andre Covre was elected on August 24, 2023, by the Board of Directors to the position of Chief Financial Officer.
Before joining DASA, he worked for 15 years at the Ultra Group, as Chief Financial and Investor Relations Officer and CEO of Extrafarma. He has also worked for multinational companies such as Unisys Corporation in the United States and ABN AMRO Capital in Europe.
Andre has a degree in Public Administration from Fundação Getúlio Vargas and an MBA from INSEAD.
Mr. Rogério Reis de Castro was elected on April 22, 2024 to the position of Hospital Operations and Oncology Officer of the Company.
Mr. Rogério has more than 20 years’ experience in the healthcare sector and joined Dasa in 2021 as General Director of the Carmo Group. In 2022, he took over as General Director of the Niterói Hospital Complex, in March 2023 he took over as Regional Director of Hospitals and Oncology in Rio de Janeiro and was elected on December 28, 2023 to the position of Chief Commercial Officer of the Company. Prior to this, Rogério was National Director of Service Operations at Fresenius Medical Care Brasil and spent approximately 4 years at Amil, where he served as Commercial Director, General Director of different hospitals, as well as Regional Director of Care Delivery.
Rogério has a degree in Medicine from Universidade Federal Fluminense, a residency in Internal Medicine from Universidade Federal Fluminense and in Rheumatology from Hospital dos Servidores do Rio de Janeiro, specialization in Leadership from Cleveland Clinic Lerner College of Medicine and in Improvement from IHI (Institute for Healthcare Improvement) and an Executive MBA in Health from COPPEAD UFRJ.
Maria José (“Majo”) was elected for the position of People & Culture Officer in February 2024.
Majo has more than 30 years of experience in people management positions, having built her career in the financial markets and services sectors in major companies and multinationals such as ABNAmro Real, Atento (Brazil and Europe), Hapvida and Cruzeiro do Sul Educacional. More recently, she was Vice President of People, Management and Sustainability at Cruzeiro do Sul Educacional and Vice President of People, Management and Diversity at Hapvida. Earlier, she worked for 13 years at Atento, including as Vice President of Human Resources, with responsibility for the company’s global cultural project. Currently, Majo is director of diversity at the Brazilian Human Resources Association.
Majo holds a degree in psychology from Universidade Paulista, a graduate degree from Fundação Álvares Penteado, has completed a specialization program in Human Resources from Fundação Getúlio Vargas and training in group studies at the Brazilian Group Dynamics Society, with an extension in Human Resources and Leadership.
Leonardo was elected for the position of Dasa’s medical officer in 2017. Previously, Leonardo served as a neuro-radiology medical officer and coordinator at the Company.
Before joining Dasa, Leonardo served as a founding partner at Medvia Diagnóstico, and chief of radiology services at Clinics Hospital in Porto Alegre.
Leonardo holds a Ph.D. in medical sciences from the Federal University of Rio Grande do Sul (UFRGS). He holds a degree in medicine from PUCRS, with graduate studies in neuro-radiology from Mount Sinai School of Medicine and graduate studies in vascular neurology from Massachusetts General Hospital.
Mrs. Tropardi was elected on 10/17/2022 by the Board of Directors Legal, Compliance, ESG, Public Relations and Internal Audit Director.
Before joining the Company, she served as Chairwoman of the 6th Chamber of the Ethics Council of Advertisement Self-Regulation Brazilian Council (CONAR) between 2016 and 2022; between 2019 and 2022, Mrs. Tropardi also held the office of National Executive Board President of Advertisers Brazilian Association (ABA).
She holds a degree and graduate studies in Law from the University of São Paulo (USP), with an MBA in Business Administration from Dom Cabral Foundation.
Helisson Brígido Andrade Lemos was elected on May 15, 2023 to serve as Products, Marketing, Analytics and Customer Experience (PMAX) Officer.
Worked for more than 17 years in Mercado Livre (NASDAQ: MELI), a leading retailer and provider of digital financial services in Latin America, reaching the position of Country General Manager, responsible for the group’s operational and financial results in Brazil.
As COO of Movile, was coresponsible for creating governance and acceleration of the group’s technology investees.
More recently, he was VP of Digital Innovation at VIA (B3: VIIA3), responsible for kicking off the Company’s digital transformation and contributing to one of the greatest turnarounds in Brazilian retail. He is also an investor and serves on the boards of human resources, technology and educational companies.
Mr. Lemos holds a degree in business administration from the Fundação Getúlio Vargas, an MBA from Escola Superior de Propaganda e Marketing and an Executive MBA from the Stanford Graduate School of Business.
Linaldo was elected on July 25, 2016 by the Board of Directors to serve as Production Officer.
He has 25 years of experience in the Supply Chain area at companies such as Kenner, Giroflex-forma, Coca-Cola, Reckitt Benckiser, ABlnBev.
Linaldo holds a B.Sc. in Chemical Engineering from Catholic University of Pernambuco, an Executive MBA from Business School São Paulo and a Green Belt from Fundação Christiano Otonni. He also completed the Supply Chain Leadership Program from Georgia Tech, University of Georgia, USA.
Board of Directors
Dr. Dulce is co-chairwoman of Dasa’s board of directors. She dedicated her professional career to healthcare and hospital operations-related activities.
In 1971, Dr. Dulce co-founded Casa de Saúde São José, the inception of Grupo Amil. Dr. Dulce was controlling shareholder of Amil Assistência Médica Internacional, Ltda. founded in 1972, which became the largest health insurance provider and operator of various hospitals and clinics in Brazil. In 2012, this company was sold to UnitedHealth Group Inc., one of the USA’s leading healthcare companies.
Dr. Dulce also held the following positions: (i) co-founder and officer at Hospital SOMICOL, currently known as Hospital Mario Lioni, and the first pediatric intensive care unit in Latin America, from 1972 to 1984; (ii) superintendent at Amil Previdência Privada, insurance company, an arm of Grupo Amil, from 1984 to 1986; (iii) customer service officer at Amil, from 1986 to 1988; (iv) superintendent at ESHO – Empresa de Serviços Hospitalares S.A., a holding of 17 hospitals, from 1988 to 1990; (v) chairwoman of the boards of directors of Amil International Insurance Company, Inc. and Amil International (Texas), Inc., insurance companies, from 1996 to 2005; (vi) vice chairwoman of Amil Participações S.A.’s board of directors, from 2007 to 2012; (vii) chairwoman of the sustainability committee, from 2012 to 2013; and (viii) chairwoman of the boards of directors of Amil LifeSciences, from 2010 to 2014, and Excellion, from 2012 to 2014, both in the management of medical training companies and research.
Dr. Dulce holds a degree in medicine from the Federal University of Rio de Janeiro (UFRJ) in 1971. She holds the following titles at UFRJ: pediatric specialist in 1972, post-PhD in medicine (master’s degree) with specialization in pediatrics in 1976, and an MBA from COPPEAD in 1984. In 2000, she obtained a Ph.D. in business administration, with a specialization in health from the University of Texas, Austin. From 1973 to 1978, Dr. Dulce was an Assistant Professor in the Pediatrics Department of the Faculty of Medicine of the Catholic University of Petrópolis.
Currently, Romeu holds the positions of co-chairman of the board of directors and member of the Company’s audit committee.
Mr. Domingues served as scientific director at Colégio Brasileiro de Radiologia e Diagnóstico por Imagem; in 2011 he held the position of chief imaging officer at Dasa. In 2012, he held the position of Dasa’s chief executive officer.
Romeu holds a degree in medicine from the Federal University of Rio de Janeiro in 1986, with a medical residency in radiology and diagnostic imaging. He completed graduate studies from Harvard University, with a qualification in magnetic resonance imaging.
Dr. Oscar is vice chairman and independent member of Dasa’s board of directors.
Currently, Dr. Oscar is a member of the following boards of directors: (i) Localiza Rent a Car S.A.; (ii) Votorantim Participações; and (iii) Omini Brasil.
From 1999 to 2003, Oscar was chairman of TIW do Brasil’s board of directors, a Canadian telecommunications company; between 1996 and 1999, he was Bunge International’s chief executive officer, a global leader in agribusiness and food industries. Before joining Bunge, Oscar was senior vice-president and partner of Booz Allen & Hamilton, Latin America. Previously, he was the chief operations officer at Ferro Corporation, Brazil.
Dr. Oscar holds a degree in chemical engineering from the Federal University of Rio de Janeiro.
Dr. Henrique is a member of Dasa’s board of directors.
Dr. Henrique held the following positions: (i) orthopedic surgeon at Hospital Rede Esho 2002 – 2005-Amil Resgate Saúde’s CEO, from 2005 to 2015; (ii) medical supplies officer at Amil International Insurance/United Healthcare and 32 hospitals, from 2005 to 2013; (iii) he participated in IPO and Road Show of Amil International Insurance, in October 2007; and, (iv) Hospital das Américas’ CEO, Brazil’s largest private hospital at that time, from 2009 to 2014.
Dr. Henrique has been a member of Rede Ímpar’s board of directors, since 2013 and Grupo Dasa, since 2016; also Patrys Investimentos Imobiliários LTDA’s CEO.
Dr. Henrique holds a degree in medicine from UNIG, Rio de Janeiro, in 2002. He holds the following titles: (i) orthopedic surgery – Federal University of Rio de Janeiro (UNI-RIO) 2003 – 2005; (ii) Executive MBA in health – UFRJ – COPPEAD – 2006 – 2007; (iii) corporate governance in family companies – IBGC (Brazilian Institute of Corporate Governance) – 2007; (iv) corporate governance in health – IBGC (Brazilian Institute of Corporate Governance) – 2009; (v) Harvard Business School – OPM IV (Owner/President Management) – 2011.
Pedro is a member of Dasa’s board of directors and served previously as the Company’s Chief Executive Officer from December 2014 to December 2023.
Mr. Bueno holds a degree in economics from the Pontifical Catholic University of Rio de Janeiro (PUC-RJ).
Currently, he is a partner of DNA Capital, a healthcare private equity firm.
Mr. Stelleo is an independent board member of Dasa.
Mr. Stelleo holds a bachelor’s degree and a Master’s degree in Mechanical Engineering from Stanford University with an MBA from Stanford Graduate School of Business. Mr. Stelleo is advisor and co-founder of Mercado Libre (NASDAQ: MELI), Latin America’s leading retail and online financial services company, over the past 23 years, he led the Brazilian operation, as regional COO and e-commerce officer. Mr. Stelleo also acts as investor, board member, and mentor for IT, consumer, education and fintech segments.
Audit Committee
Mrs. Viviane Pinto Mendes holds the position of a member of the audit committee of Dasa and controllership manager at Signo Investimentos.
Her professional experience over the past five years includes Rede Impar and Signo Investimentos, companies in the health and investments sectors, respectively. Previously, she held the positions of internal controls manager, controller, member of the audit committee, and executive.
Currently, Romeu holds the positions of co-chairman of the board of directors and member of the Company’s audit committee.
Mr. Domingues served as scientific director at Colégio Brasileiro de Radiologia e Diagnóstico por Imagem; in 2011 he held the position of chief imaging officer at Dasa. In 2012, he held the position of Dasa’s chief executive officer.
Romeu holds a degree in medicine from the Federal University of Rio de Janeiro in 1986, with a medical residency in radiology and diagnostic imaging. He completed graduate studies from Harvard University, with a qualification in magnetic resonance imaging.
Denis Cuenca was elected Coordinator of the Audit Committee by the Board of Directors on April 16, 2024.
Denis holds a bachelor’s degree in Business Administration and an MBA in Business Management. He has 35 years of executive experience in External and Internal Audit, Risk and Crisis Management, Compliance, Integrity Management and Whistleblowing Channel at KPMG, Itaú and Ultrapar.
Currently, he is Chief Global Audit and Compliance Officer and Conduct Committee Coordinator at Vale S/A. Since July 2023, he has also been a member of the Audit Committee of AEGEA Saneamento and member of the Excellence in Risks Committee at the Regional Administration Council (CRA). Between 2014 and 2017, he was the Corporate Governance Secretary at the Brazilian Institute of Corporate Governance (IBGC)
The Internal Regulation of the Audit Committee was duly approved by the Company’s Board of Directors on May 13, 2021 and is available: (i) at the Company’s headquarters: Avenida Juruá, 434, Alphaville, CEP 06455-010, Barueri/SP; and (ii) on the Company’s website (www.dasa.com.br).